Assembly Bill 522, introduced in the Nevada State Legislature on April 24, 2025, aims to enhance healthcare coverage for sexually transmitted diseases (STDs) and related preventive measures. The bill mandates comprehensive coverage for testing, treatment, and prevention of STDs, including Chlamydia, gonorrhea, syphilis, HIV, and hepatitis B and C, for all enrollees, regardless of age. Notably, it also requires unrestricted access to condoms for individuals aged 13 and older.

Key provisions of the bill prohibit health maintenance organizations from imposing higher deductibles, copayments, or waiting periods for these benefits. Additionally, it prevents insurers from denying coverage based on an individual's use of these services or penalizing healthcare providers who offer them. The bill is set to take effect for health care plans issued or renewed on or after October 1, 2025.

The introduction of AB522 has sparked discussions among lawmakers and health advocates. Proponents argue that the bill addresses significant public health concerns by increasing access to essential health services, particularly for young people who may be at higher risk for STDs. Critics, however, express concerns about the potential financial implications for health maintenance organizations and the broader healthcare system.

The bill's passage could have substantial social implications, potentially reducing the rates of STDs in Nevada and improving overall public health outcomes. Experts suggest that by removing financial barriers to testing and treatment, AB522 could lead to earlier diagnosis and treatment, ultimately lowering transmission rates.

As the legislative session progresses, stakeholders will closely monitor the bill's developments, anticipating debates over its economic impact and the balance between public health needs and insurance industry concerns. The outcome of AB522 could set a precedent for similar health initiatives in other states, emphasizing the importance of accessible healthcare in combating STDs.